Essex Financial Services’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Sell
4,739
-552
-10% -$25.7K 0.01% 711
2025
Q4
$256K Buy
5,291
+973
+23% +$48.2K 0.01% 663
2025
Q3
$204K Buy
+4,318
New +$208K 0.01% 718
2025
Q2
Sell
-4,557
Closed -$253K 705
2025
Q1
$253K Buy
+4,557
New +$247K 0.02% 541
2024
Q3
Sell
-3,867
Closed -$202K 652
2024
Q2
$202K Buy
+3,867
New +$187K 0.02% 589
2023
Q4
Sell
-4,088
Closed -$219K 519
2023
Q3
$219K Sell
4,088
-111
-3% -$5.92K 0.03% 429
2023
Q2
$226K Sell
4,199
-499
-11% -$26.9K 0.03% 420
2023
Q1
$256K Buy
4,698
+548
+13% +$26.7K 0.03% 411
2022
Q4
$200K Buy
+4,150
New +$182K 0.02% 456
2022
Q3
Sell
-4,197
Closed -$210K 486
2022
Q2
$210K Buy
4,197
+51
+1% +$2.71K 0.02% 453
2022
Q1
$213K Hold
4,146
0.02% 465
2021
Q4
$208K Buy
+4,146
New +$205K 0.02% 470
2021
Q3
Sell
-4,768
Closed -$236K 481
2021
Q2
$236K Hold
4,768
0.03% 389
2021
Q1
$236K Sell
4,768
-500
-9% -$24K 0.04% 312
2020
Q4
$256K Sell
5,268
-430
-8% -$21.2K 0.05% 264
2020
Q3
$286K Sell
5,698
-1
-0% -$51 0.07% 222
2020
Q2
$291K Buy
5,699
+291
+5% +$14.1K 0.09% 196
2020
Q1
$236K Sell
5,408
-1
-0% -$48 0.08% 212
2019
Q4
$272K Sell
5,409
-1,086
-17% -$50.9K 0.08% 222
2019
Q3
$301K Sell
6,495
-344
-5% -$14.8K 0.1% 184
2019
Q2
$296K Buy
6,839
+10
+0.1% +$425 0.09% 181
2019
Q1
$302K Sell
6,829
-500
-7% -$21.4K 0.09% 171
2018
Q4
$318K Sell
7,329
-685
-9% -$30.2K 0.1% 173
2018
Q3
$358K Hold
8,014
0.08% 193
2018
Q2
$321K Sell
8,014
-739
-8% -$29.1K 0.08% 203
2018
Q1
$351K Sell
8,753
-779
-8% -$32.4K 0.07% 238
2017
Q4
$410K Sell
9,532
-1,250
-12% -$57.6K 0.1% 176
2017
Q3
$537K Sell
10,782
-116
-1% -$5.61K 0.13% 146
2017
Q2
$522K Sell
10,898
-45
-0.4% -$2.15K 0.11% 182
2017
Q1
$495K Sell
10,943
-1,010
-8% -$42.8K 0.11% 177
2016
Q4
$483K Buy
11,953
+1,273
+12% +$50.2K 0.1% 181
2016
Q3
$408K Sell
10,680
-260
-2% -$10.4K 0.1% 197
2016
Q2
$458K Sell
10,940
-634
-5% -$26K 0.11% 177
2016
Q1
$465K Sell
11,574
-2,420
-17% -$97.2K 0.12% 178
2015
Q4
$597K Sell
13,994
-1,807
-11% -$83.1K 0.14% 158
2015
Q3
$750K Sell
15,801
-776
-5% -$39.5K 0.19% 124
2015
Q2
$821K Sell
16,577
-1,408
-8% -$71.4K 0.21% 117
2015
Q1
$889K Buy
17,985
+6,975
+63% +$333K 0.23% 115
2014
Q4
$502K Sell
11,010
-1,457
-12% -$70.7K 0.13% 173
2014
Q3
$704K Sell
12,467
-837
-6% -$45K 0.21% 120
2014
Q2
$707K Buy
13,304
+459
+4% +$24.4K 0.21% 114
2014
Q1
$672K Buy
12,845
+2,370
+23% +$120K 0.22% 109
2013
Q4
$562K Sell
10,475
-2,010
-16% -$104K 0.19% 124
2013
Q3
$632 Buy
12,485
+290
+2% +$14.8K 0.2% 106
2013
Q2
$628K Buy
+12,195
New +$650K 0.22% 108

Other funds holding SNY

Essex Financial Services's SNY Position: Q1 2026 in Review

Essex Financial Services reduced its Sanofi (SNY) stake by 10% in Q1 2026, selling an estimated $25.7K and leaving 4,739 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #711.

Essex Financial Services first reported a position in SNY in Q2 2013 and has held it in 45 quarters since. The position peaked at $889K in Q1 2015. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Essex Financial Services held 4,739 shares of Sanofi worth $228K as of Q1 2026.
  • Essex Financial Services sold 552 Sanofi shares in Q1 2026, an estimated $25.7K.
  • Sanofi made up 0.01% of Essex Financial Services's portfolio in Q1 2026, its #711 holding.
  • Essex Financial Services first reported a position in Sanofi in Q2 2013 and has held it in 45 quarters since.
  • Essex Financial Services's Sanofi position peaked at $889K in Q1 2015.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.